Exploring the connections between disease mechanisms and outcomes in rheumatic diseases.
Official title: Linking Disease Mechanisms and Outcomes in Rheumatic Diseases
Funded at University of Michigan at Ann Arbor · NIH-10877823 · Data updated 2026-11-12
This study is all about helping new researchers learn how to better understand and study rheumatic diseases like lupus and fibromyalgia, so they can improve pain management and overall care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | July 6, 2020 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $134,997 |
| NIH project number | 5K24AR076975-05 |
| Project ID | NIH-10877823 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with rheumatic diseases, particularly those experiencing chronic pain.
✕Less likely to help
Patients with non-rheumatic conditions or those not experiencing chronic pain may not benefit from this research.
What this research studies
This research focuses on enhancing mentorship in patient-oriented research related to rheumatic diseases, particularly pain management. The principal investigator will dedicate a portion of their time to train and guide new researchers in understanding the complexities of these diseases and their impact on patients. By collaborating with established centers, the project aims to improve research methodologies and biostatistics skills, ultimately leading to better patient outcomes. The initiative will also explore the biological aspects of conditions like lupus and fibromyalgia.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and outcomes for patients suffering from rheumatic diseases.
How similar studies have gone: Previous research has shown that enhanced mentorship in clinical research can lead to significant advancements in patient care and treatment outcomes.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Kahlenberg, Joanne Michelle — University of Michigan at Ann Arbor
- Study coordinator: Kahlenberg, Joanne Michelle
Related research
Other NIH-funded projects on the same topics.
-
Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups with Rheumatic Diseases
A patient-facing program tests a multi-modal approach using storytelling videos and trained patient navigators to help Black and Latinx adults with autoimmune rheumatic diseases get recommended COVID-19 vaccines and boosters.
-
How health policies affect people with systemic autoimmune and rheumatic conditions
This project looks at how health policies and medical care affect health and pregnancy outcomes for reproductive-age women with systemic autoimmune and rheumatic diseases.
-
Long-term immune and health effects of COVID-19 in people with autoimmune rheumatic diseases
This project looks at how COVID-19 changes immune responses and causes lingering symptoms in people with autoimmune rheumatic diseases like rheumatoid arthritis and lupus.
-
How health policies impact women with autoimmune diseases during pregnancy
This study is looking at how health policies affect women with autoimmune and rheumatic diseases during pregnancy, aiming to understand their experiences and access to care, so we can better support their health and treatment options.
-
Training new scientists in rheumatic diseases
This program is training new scientists to explore the causes and treatments of rheumatic diseases, like arthritis, by working together at the University of Pennsylvania and the Children’s Hospital of Philadelphia, so they can help improve care for patients of all ages.
-
Helping Black and Latinx patients with rheumatic diseases get recommended COVID-19 vaccines
This project helps Black and Latinx adults living with autoimmune rheumatic diseases get their recommended COVID-19 vaccines.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.